vs

Side-by-side financial comparison of PTC THERAPEUTICS, INC. (PTCT) and SPS COMMERCE INC (SPSC). Click either name above to swap in a different company.

SPS COMMERCE INC is the larger business by last-quarter revenue ($192.7M vs $164.7M, roughly 1.2× PTC THERAPEUTICS, INC.). SPS COMMERCE INC runs the higher net margin — 13.4% vs -82.0%, a 95.4% gap on every dollar of revenue. On growth, SPS COMMERCE INC posted the faster year-over-year revenue change (12.7% vs -22.7%). SPS COMMERCE INC produced more free cash flow last quarter ($38.2M vs $-36.6M). Over the past eight quarters, SPS COMMERCE INC's revenue compounded faster (13.5% CAGR vs -11.5%).

PTC Therapeutics, Inc. is a US pharmaceutical company focused on the development of orally administered small molecule drugs and gene therapy which regulate gene expression by targeting post-transcriptional control (PTC) mechanisms in orphan diseases.

SPS Commerce, Inc. is a technology and application software company based in the United States that provides cloud-based supply chain management software. The company's headquarters are located in Minneapolis, Minnesota, but it also has a US office in New Jersey, and international locations in Amsterdam, Beijing, Breukelen, Hong Kong, Kyiv, Melbourne, Montpellier, Sydney, and Toronto.

PTCT vs SPSC — Head-to-Head

Bigger by revenue
SPSC
SPSC
1.2× larger
SPSC
$192.7M
$164.7M
PTCT
Growing faster (revenue YoY)
SPSC
SPSC
+35.5% gap
SPSC
12.7%
-22.7%
PTCT
Higher net margin
SPSC
SPSC
95.4% more per $
SPSC
13.4%
-82.0%
PTCT
More free cash flow
SPSC
SPSC
$74.9M more FCF
SPSC
$38.2M
$-36.6M
PTCT
Faster 2-yr revenue CAGR
SPSC
SPSC
Annualised
SPSC
13.5%
-11.5%
PTCT

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
PTCT
PTCT
SPSC
SPSC
Revenue
$164.7M
$192.7M
Net Profit
$-135.0M
$25.8M
Gross Margin
70.4%
Operating Margin
-43.3%
18.0%
Net Margin
-82.0%
13.4%
Revenue YoY
-22.7%
12.7%
Net Profit YoY
-104.8%
47.2%
EPS (diluted)
$-1.63
$0.69

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
PTCT
PTCT
SPSC
SPSC
Q4 25
$164.7M
$192.7M
Q3 25
$211.0M
$189.9M
Q2 25
$178.9M
$187.4M
Q1 25
$1.2B
$181.5M
Q4 24
$213.2M
$170.9M
Q3 24
$196.8M
$163.7M
Q2 24
$186.7M
$153.6M
Q1 24
$210.1M
$149.6M
Net Profit
PTCT
PTCT
SPSC
SPSC
Q4 25
$-135.0M
$25.8M
Q3 25
$15.9M
$25.6M
Q2 25
$-64.8M
$19.7M
Q1 25
$866.6M
$22.2M
Q4 24
$-65.9M
$17.6M
Q3 24
$-106.7M
$23.5M
Q2 24
$-99.2M
$18.0M
Q1 24
$-91.6M
$18.0M
Gross Margin
PTCT
PTCT
SPSC
SPSC
Q4 25
70.4%
Q3 25
69.5%
Q2 25
68.1%
Q1 25
68.7%
Q4 24
67.5%
Q3 24
68.5%
Q2 24
66.1%
Q1 24
65.6%
Operating Margin
PTCT
PTCT
SPSC
SPSC
Q4 25
-43.3%
18.0%
Q3 25
1.4%
16.4%
Q2 25
-19.5%
14.1%
Q1 25
82.5%
14.3%
Q4 24
-76.2%
14.5%
Q3 24
-27.7%
15.6%
Q2 24
-21.5%
15.1%
Q1 24
-21.6%
10.3%
Net Margin
PTCT
PTCT
SPSC
SPSC
Q4 25
-82.0%
13.4%
Q3 25
7.5%
13.5%
Q2 25
-36.3%
10.5%
Q1 25
73.7%
12.2%
Q4 24
-30.9%
10.3%
Q3 24
-54.2%
14.3%
Q2 24
-53.1%
11.7%
Q1 24
-43.6%
12.0%
EPS (diluted)
PTCT
PTCT
SPSC
SPSC
Q4 25
$-1.63
$0.69
Q3 25
$0.20
$0.67
Q2 25
$-0.83
$0.52
Q1 25
$10.04
$0.58
Q4 24
$-0.85
$0.46
Q3 24
$-1.39
$0.62
Q2 24
$-1.29
$0.48
Q1 24
$-1.20
$0.48

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
PTCT
PTCT
SPSC
SPSC
Cash + ST InvestmentsLiquidity on hand
$1.9B
$151.4M
Total DebtLower is stronger
Stockholders' EquityBook value
$-205.3M
$973.9M
Total Assets
$2.9B
$1.2B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
PTCT
PTCT
SPSC
SPSC
Q4 25
$1.9B
$151.4M
Q3 25
$1.7B
$133.7M
Q2 25
$2.0B
$107.6M
Q1 25
$2.0B
$94.9M
Q4 24
$1.1B
$241.0M
Q3 24
$1.0B
$205.8M
Q2 24
$1.1B
$271.8M
Q1 24
$884.8M
$290.8M
Stockholders' Equity
PTCT
PTCT
SPSC
SPSC
Q4 25
$-205.3M
$973.9M
Q3 25
$-155.8M
$958.9M
Q2 25
$-206.5M
$949.8M
Q1 25
$-185.8M
$920.9M
Q4 24
$-1.1B
$854.7M
Q3 24
$-1.1B
$829.4M
Q2 24
$-980.2M
$703.4M
Q1 24
$-893.9M
$683.0M
Total Assets
PTCT
PTCT
SPSC
SPSC
Q4 25
$2.9B
$1.2B
Q3 25
$2.6B
$1.2B
Q2 25
$2.6B
$1.1B
Q1 25
$2.7B
$1.1B
Q4 24
$1.7B
$1.0B
Q3 24
$1.8B
$1.0B
Q2 24
$1.9B
$854.5M
Q1 24
$1.8B
$839.8M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
PTCT
PTCT
SPSC
SPSC
Operating Cash FlowLast quarter
$-34.3M
$45.9M
Free Cash FlowOCF − Capex
$-36.6M
$38.2M
FCF MarginFCF / Revenue
-22.3%
19.8%
Capex IntensityCapex / Revenue
1.4%
4.0%
Cash ConversionOCF / Net Profit
1.78×
TTM Free Cash FlowTrailing 4 quarters
$702.3M
$152.3M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
PTCT
PTCT
SPSC
SPSC
Q4 25
$-34.3M
$45.9M
Q3 25
$-66.3M
$60.6M
Q2 25
$-58.3M
$32.3M
Q1 25
$870.1M
$40.0M
Q4 24
$-30.0M
$40.6M
Q3 24
$-77.0M
$53.3M
Q2 24
$-71.5M
$29.4M
Q1 24
$70.8M
$34.1M
Free Cash Flow
PTCT
PTCT
SPSC
SPSC
Q4 25
$-36.6M
$38.2M
Q3 25
$-69.7M
$54.6M
Q2 25
$-59.6M
$25.7M
Q1 25
$868.4M
$33.8M
Q4 24
$-33.8M
$34.3M
Q3 24
$-77.5M
$48.1M
Q2 24
$-78.8M
$24.4M
Q1 24
$61.2M
$30.5M
FCF Margin
PTCT
PTCT
SPSC
SPSC
Q4 25
-22.3%
19.8%
Q3 25
-33.1%
28.7%
Q2 25
-33.3%
13.7%
Q1 25
73.8%
18.6%
Q4 24
-15.8%
20.1%
Q3 24
-39.4%
29.4%
Q2 24
-42.2%
15.9%
Q1 24
29.1%
20.4%
Capex Intensity
PTCT
PTCT
SPSC
SPSC
Q4 25
1.4%
4.0%
Q3 25
1.6%
3.2%
Q2 25
0.7%
3.6%
Q1 25
0.1%
3.4%
Q4 24
1.8%
3.6%
Q3 24
0.3%
3.2%
Q2 24
4.0%
3.3%
Q1 24
4.6%
2.4%
Cash Conversion
PTCT
PTCT
SPSC
SPSC
Q4 25
1.78×
Q3 25
-4.17×
2.37×
Q2 25
1.64×
Q1 25
1.00×
1.80×
Q4 24
2.31×
Q3 24
2.27×
Q2 24
1.63×
Q1 24
1.89×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

PTCT
PTCT

Segment breakdown not available.

SPSC
SPSC

Recurring Revenues$184.5M96%
One Time Revenues$8.1M4%
Set Up Fees$4.1M2%

Related Comparisons